FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, namely a thixotropic oral pharmaceutical composition for drug delivery. The thixotropic pharmaceutical composition contains a pharmacologically active substance, a liquid substrate, a biocompatible gel former having the pre-set thixotropic properties and specified in agar, carrageenin and gellan gum.
EFFECT: composition provides the accurate introduction of the amounts of drugs into a patient, a high degree of appreciation of a drug dose by the patient.
8 cl, 3 dwg, 10 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION OF SILDENAFIL CITRATE IN FORM OF SUSPENSION FOR ORAL ADMINISTRATION | 2016 |
|
RU2649834C1 |
| EASILY DOSED SOLID MEDICINAL PREPARATION | 2011 |
|
RU2574018C2 |
| SYSTEM FOR PROLONGED RELEASE OF SOLUBLE DRUG | 2002 |
|
RU2322263C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING DRUG HAVING POOR WATER SOLUBILITY | 2012 |
|
RU2678587C2 |
| FAST DISPERSIBLE PREGELATINISED STARCHES FOR USE IN FOOD PRODUCTS | 2004 |
|
RU2342853C2 |
| PAZOPANIB COMPOSITION | 2012 |
|
RU2616500C2 |
| BISMUTH-CONTAINING LIQUID PHARMACEUTICAL SUSPENSIONS | 2015 |
|
RU2676261C2 |
| MEANS FOR TREATING THERMAL BURNS | 2018 |
|
RU2681944C1 |
| LIQUID COMPOSITIONS CONTAINING TASIMELTEON AND METHODS OF THEIR USE | 2020 |
|
RU2806302C1 |
| GINDARINE COMPOSITION | 2007 |
|
RU2372912C2 |
